0
Upcoming Allied Market Research
2023
Healthcare Business Intelligence Market

Healthcare Business Intelligence Market

by Component (Software, Services, Platforms), by Function (OLAP and Visualization, Query and Reporting, Performance Management), by Application (Financial Analysis, Operational Analysis, Clinical Analysis), by Deployment model (On premise Model, Cloud based Model, Hybrid Model) and by End User (Healthcare Manufacturers, Healthcare Providers, Payers, Other End Users): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A09499
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Healthcare Business Intelligence Market

Request Now !

There is an increase in the growth of healthcare business intelligence market due to factors such assurge in promotion ofbusiness intelligence software by hospitals, healthcare providers, payers, and life sciences manufacturers to transform their data into valuable information and graphs is animportant factor responsible to drive the growth of the market. Business intelligence platform provides end users with the useful information that permits them to manage revenues, service rate comparisons, patient admission trends, patient care status, and easy access to patient data by age, gender, and Emergency Room visits without any actual visit.

Business Intelligence (BI) in the healthcare sector raises patient care and decreases expenses. Due to complications of data generation in healthcare system. Healthcare Business intelligence applications are required in hospitals and other healthcare organizations to gain patient satisfaction, productive clinical operations, distribution of work, daily practice of nurses and doctors, and constructive management and administration.

COVID-19 scenario analysis:

With the outbreak of COVID-19 globally and the stipulated lockout, there is an ongoing downturn in the healthcare market. Apart from communities, COVID-19 was equally disastrous for major world economies, especially the healthcare sector. Prominent stakeholders are continuing to adapt their strategy to the rapidly changing situation. COVID-19 is projected to have significant long-term impacts on the healthcare industry. Countries and major players would have to undertake critical healthcare changes until the crisis takes a back seat.

Technological progress, cost containment and increased access will in the near future be an integral part of healthcare reforms. Digital health and telehealth have taken a front seat in the ongoing outbreak. COVID-19 re-emphasized the importance of remote diagnosis, care and consultation. Over the past few years, regulatory and behavioral barriers have slowed Telehealth growth. However, since many healthcare providers are currently working on video conferencing and telephone calls, its growth is anticipated to increase several folds over the next two years.

Top Impacting factors:

  • Increase in adoption of artificial intelligence in the healthcare sector is boosting the market growth of healthcare business intelligence. Innovative developments such asbig data implementation and initiatives to upgrade healthcare solutions are propelling the healthcare business intelligence market.
  • Increase in number of patients and their information feed in the database to make registries has become anunmanageable task and to manage such difficult work, digital innovations developed electronic health record system which is boosting the healthcare business intelligence market greatly.
  • Advancements inInformationtechnology  and cloud services  builds up the  healthcare infrastructure which is boosting the  growth  of healthcare business intelligence market which is totally supported by the IT professionals  targeting developing  economies providing healthcare services. Thesedriving factors are boosting the business development of healthcare business intelligence market drastically.

New Product Launches:

  • In 2018, Oracle obtained  Zenedge (US) to firm critical IT systems used through cloud, on-premise, or hybrid hosting environments with the help of Zenedge
  • In 2018, SAS made an agreement with Deloitte (Canada) to support their existing strategic alliance that will grip the experts to lower the risk and provide higher-quality outcomes in the insurance market.
  • In 2017, Microsoft made partnership with SAP SE (Germany) to grow more business innovation in the cloud and provide joint support services to provide the best cloud experience to the customers.

Surge in the growth of healthcare business intelligence market:

  • Healthcare Business intelligence market is expected grow in future of healthcare industry as it has the capability to positively influence the benefiters including patients, clinical staff, physicians, employers, payers, and providers. This is expected to boost the market growth of healthcare business intelligence market.

Key benefits of the report:

  • This study presents the analytical depiction of the global healthcare business intelligence market along with the current trends and future estimations to determine the investments.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of thehealthcare business intelligence market share.
  • The current market is quantitatively analyzed to highlight thehealthcare business intelligence market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed globalhealthcare business intelligencemarket analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in theHealthcare Business IntelligenceMarket Report:

  • What are the leading market players active in healthcare business intelligence industry?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
  • What Segments and region will drive the market growth & why?

Healthcare Business Intelligence Market Report Highlights

Aspects Details
By Component
  • Software
  • Services
  • Platforms
By Function
  • OLAP and Visualization
  • Query and Reporting
  • Performance Management
By Application
  • Financial Analysis
    • Revenue Cycle Management
    • Claims Processing
    • Payment Integrity and Fraud, Waste and Abuse (FWA)
    • Risk Adjustment & Risk Assessment
  • Operational Analysis
    • Workforce Analysis
    • Supply Chain Analysis
    • Strategic Analysis
  • Clinical Analysis
    • Clinical Decision Support
    • Quality Improvement & Clinical Benchmarking
    • Clinical Decision Support
    • Regulatory Reporting and Compliance
    • Comparative Analytics/Effectiveness
    • Precision Health
By Deployment model
  • On premise Model
  • Cloud based Model
  • Hybrid Model
By End User
  • Healthcare Manufacturers
  • Healthcare Providers
    • Hospitals andPhysicians
    • Post acute Care Organizations
    • Ambulatory Care Settings
  • Payers
    • Government Agencies
    • Private Insurance Companies
    • Employers and Private Exchanges
  • Other End Users
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Oracle, IBM, Tableau Software, QlikTech International AB, SAPSE, Information Builders, MicroStrategy Incorporated, Microsoft, Yellowfin BI
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: HEALTHCARE BUSINESS INTELLIGENCE MARKET, BY COMPONENT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Component

    • 4.2. Software

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Services

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Platforms

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: HEALTHCARE BUSINESS INTELLIGENCE MARKET, BY FUNCTION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Function

    • 5.2. OLAP And Visualization

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Query And Reporting

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Performance Management

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: HEALTHCARE BUSINESS INTELLIGENCE MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Financial Analysis

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

      • 6.2.4. Revenue Cycle Management

        • 6.2.4.1. Market Size and Forecast
      • 6.2.4. Claims Processing

        • 6.2.4.1. Market Size and Forecast
      • 6.2.4. Payment Integrity and Fraud, Waste and Abuse (FWA)

        • 6.2.4.1. Market Size and Forecast
      • 6.2.4. Risk Adjustment Risk Assessment

        • 6.2.4.1. Market Size and Forecast
    • 6.3. Operational Analysis

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

      • 6.3.4. Workforce Analysis

        • 6.3.4.1. Market Size and Forecast
      • 6.3.4. Supply Chain Analysis

        • 6.3.4.1. Market Size and Forecast
      • 6.3.4. Strategic Analysis

        • 6.3.4.1. Market Size and Forecast
    • 6.4. Clinical Analysis

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

      • 6.4.4. Clinical Decision Support

        • 6.4.4.1. Market Size and Forecast
      • 6.4.4. Quality Improvement Clinical Benchmarking

        • 6.4.4.1. Market Size and Forecast
      • 6.4.4. Clinical Decision Support

        • 6.4.4.1. Market Size and Forecast
      • 6.4.4. Regulatory Reporting and Compliance

        • 6.4.4.1. Market Size and Forecast
      • 6.4.4. Comparative Analytics/Effectiveness

        • 6.4.4.1. Market Size and Forecast
      • 6.4.4. Precision Health

        • 6.4.4.1. Market Size and Forecast
  • CHAPTER 7: HEALTHCARE BUSINESS INTELLIGENCE MARKET, BY DEPLOYMENT MODEL

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Deployment Model

    • 7.2. On Premise Model

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Cloud Based Model

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Hybrid Model

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

  • CHAPTER 8: HEALTHCARE BUSINESS INTELLIGENCE MARKET, BY END USER

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By End User

    • 8.2. Healthcare Manufacturers

      • 8.2.1. Key Market Trends, Growth Factors and Opportunities

      • 8.2.2. Market Size and Forecast, By Region

      • 8.2.3. Market Share Analysis, By Country

    • 8.3. Healthcare Providers

      • 8.3.1. Key Market Trends, Growth Factors and Opportunities

      • 8.3.2. Market Size and Forecast, By Region

      • 8.3.3. Market Share Analysis, By Country

      • 8.3.4. Hospitals andPhysicians

        • 8.3.4.1. Market Size and Forecast
      • 8.3.4. Post acute Care Organizations

        • 8.3.4.1. Market Size and Forecast
      • 8.3.4. Ambulatory Care Settings

        • 8.3.4.1. Market Size and Forecast
    • 8.4. Payers

      • 8.4.1. Key Market Trends, Growth Factors and Opportunities

      • 8.4.2. Market Size and Forecast, By Region

      • 8.4.3. Market Share Analysis, By Country

      • 8.4.4. Government Agencies

        • 8.4.4.1. Market Size and Forecast
      • 8.4.4. Private Insurance Companies

        • 8.4.4.1. Market Size and Forecast
      • 8.4.4. Employers and Private Exchanges

        • 8.4.4.1. Market Size and Forecast
    • 8.5. Other End Users

      • 8.5.1. Key Market Trends, Growth Factors and Opportunities

      • 8.5.2. Market Size and Forecast, By Region

      • 8.5.3. Market Share Analysis, By Country

  • CHAPTER 9: HEALTHCARE BUSINESS INTELLIGENCE MARKET, BY REGION

    • 9.1. Market Overview

      • 9.1.1 Market Size and Forecast, By Region

    • 9.2. North America

      • 9.2.1. Key Market Trends and Opportunities

      • 9.2.2. Market Size and Forecast, By Component

      • 9.2.3. Market Size and Forecast, By Function

      • 9.2.4. Market Size and Forecast, By Application

      • 9.2.5. Market Size and Forecast, By Deployment Model

      • 9.2.6. Market Size and Forecast, By End User

      • 9.2.7. Market Size and Forecast, By Country

      • 9.2.8. U.S. Healthcare Business Intelligence Market

        • 9.2.8.1. Market Size and Forecast, By Component
        • 9.2.8.2. Market Size and Forecast, By Function
        • 9.2.8.3. Market Size and Forecast, By Application
        • 9.2.8.4. Market Size and Forecast, By Deployment Model
        • 9.2.8.5. Market Size and Forecast, By End User
      • 9.2.9. Canada Healthcare Business Intelligence Market

        • 9.2.9.1. Market Size and Forecast, By Component
        • 9.2.9.2. Market Size and Forecast, By Function
        • 9.2.9.3. Market Size and Forecast, By Application
        • 9.2.9.4. Market Size and Forecast, By Deployment Model
        • 9.2.9.5. Market Size and Forecast, By End User
      • 9.2.10. Mexico Healthcare Business Intelligence Market

        • 9.2.10.1. Market Size and Forecast, By Component
        • 9.2.10.2. Market Size and Forecast, By Function
        • 9.2.10.3. Market Size and Forecast, By Application
        • 9.2.10.4. Market Size and Forecast, By Deployment Model
        • 9.2.10.5. Market Size and Forecast, By End User
    • 9.3. Europe

      • 9.3.1. Key Market Trends and Opportunities

      • 9.3.2. Market Size and Forecast, By Component

      • 9.3.3. Market Size and Forecast, By Function

      • 9.3.4. Market Size and Forecast, By Application

      • 9.3.5. Market Size and Forecast, By Deployment Model

      • 9.3.6. Market Size and Forecast, By End User

      • 9.3.7. Market Size and Forecast, By Country

      • 9.3.8. France Healthcare Business Intelligence Market

        • 9.3.8.1. Market Size and Forecast, By Component
        • 9.3.8.2. Market Size and Forecast, By Function
        • 9.3.8.3. Market Size and Forecast, By Application
        • 9.3.8.4. Market Size and Forecast, By Deployment Model
        • 9.3.8.5. Market Size and Forecast, By End User
      • 9.3.9. Germany Healthcare Business Intelligence Market

        • 9.3.9.1. Market Size and Forecast, By Component
        • 9.3.9.2. Market Size and Forecast, By Function
        • 9.3.9.3. Market Size and Forecast, By Application
        • 9.3.9.4. Market Size and Forecast, By Deployment Model
        • 9.3.9.5. Market Size and Forecast, By End User
      • 9.3.10. Italy Healthcare Business Intelligence Market

        • 9.3.10.1. Market Size and Forecast, By Component
        • 9.3.10.2. Market Size and Forecast, By Function
        • 9.3.10.3. Market Size and Forecast, By Application
        • 9.3.10.4. Market Size and Forecast, By Deployment Model
        • 9.3.10.5. Market Size and Forecast, By End User
      • 9.3.11. Spain Healthcare Business Intelligence Market

        • 9.3.11.1. Market Size and Forecast, By Component
        • 9.3.11.2. Market Size and Forecast, By Function
        • 9.3.11.3. Market Size and Forecast, By Application
        • 9.3.11.4. Market Size and Forecast, By Deployment Model
        • 9.3.11.5. Market Size and Forecast, By End User
      • 9.3.12. UK Healthcare Business Intelligence Market

        • 9.3.12.1. Market Size and Forecast, By Component
        • 9.3.12.2. Market Size and Forecast, By Function
        • 9.3.12.3. Market Size and Forecast, By Application
        • 9.3.12.4. Market Size and Forecast, By Deployment Model
        • 9.3.12.5. Market Size and Forecast, By End User
      • 9.3.13. Russia Healthcare Business Intelligence Market

        • 9.3.13.1. Market Size and Forecast, By Component
        • 9.3.13.2. Market Size and Forecast, By Function
        • 9.3.13.3. Market Size and Forecast, By Application
        • 9.3.13.4. Market Size and Forecast, By Deployment Model
        • 9.3.13.5. Market Size and Forecast, By End User
      • 9.3.14. Rest Of Europe Healthcare Business Intelligence Market

        • 9.3.14.1. Market Size and Forecast, By Component
        • 9.3.14.2. Market Size and Forecast, By Function
        • 9.3.14.3. Market Size and Forecast, By Application
        • 9.3.14.4. Market Size and Forecast, By Deployment Model
        • 9.3.14.5. Market Size and Forecast, By End User
    • 9.4. Asia-Pacific

      • 9.4.1. Key Market Trends and Opportunities

      • 9.4.2. Market Size and Forecast, By Component

      • 9.4.3. Market Size and Forecast, By Function

      • 9.4.4. Market Size and Forecast, By Application

      • 9.4.5. Market Size and Forecast, By Deployment Model

      • 9.4.6. Market Size and Forecast, By End User

      • 9.4.7. Market Size and Forecast, By Country

      • 9.4.8. China Healthcare Business Intelligence Market

        • 9.4.8.1. Market Size and Forecast, By Component
        • 9.4.8.2. Market Size and Forecast, By Function
        • 9.4.8.3. Market Size and Forecast, By Application
        • 9.4.8.4. Market Size and Forecast, By Deployment Model
        • 9.4.8.5. Market Size and Forecast, By End User
      • 9.4.9. Japan Healthcare Business Intelligence Market

        • 9.4.9.1. Market Size and Forecast, By Component
        • 9.4.9.2. Market Size and Forecast, By Function
        • 9.4.9.3. Market Size and Forecast, By Application
        • 9.4.9.4. Market Size and Forecast, By Deployment Model
        • 9.4.9.5. Market Size and Forecast, By End User
      • 9.4.10. India Healthcare Business Intelligence Market

        • 9.4.10.1. Market Size and Forecast, By Component
        • 9.4.10.2. Market Size and Forecast, By Function
        • 9.4.10.3. Market Size and Forecast, By Application
        • 9.4.10.4. Market Size and Forecast, By Deployment Model
        • 9.4.10.5. Market Size and Forecast, By End User
      • 9.4.11. South Korea Healthcare Business Intelligence Market

        • 9.4.11.1. Market Size and Forecast, By Component
        • 9.4.11.2. Market Size and Forecast, By Function
        • 9.4.11.3. Market Size and Forecast, By Application
        • 9.4.11.4. Market Size and Forecast, By Deployment Model
        • 9.4.11.5. Market Size and Forecast, By End User
      • 9.4.12. Australia Healthcare Business Intelligence Market

        • 9.4.12.1. Market Size and Forecast, By Component
        • 9.4.12.2. Market Size and Forecast, By Function
        • 9.4.12.3. Market Size and Forecast, By Application
        • 9.4.12.4. Market Size and Forecast, By Deployment Model
        • 9.4.12.5. Market Size and Forecast, By End User
      • 9.4.13. Thailand Healthcare Business Intelligence Market

        • 9.4.13.1. Market Size and Forecast, By Component
        • 9.4.13.2. Market Size and Forecast, By Function
        • 9.4.13.3. Market Size and Forecast, By Application
        • 9.4.13.4. Market Size and Forecast, By Deployment Model
        • 9.4.13.5. Market Size and Forecast, By End User
      • 9.4.14. Malaysia Healthcare Business Intelligence Market

        • 9.4.14.1. Market Size and Forecast, By Component
        • 9.4.14.2. Market Size and Forecast, By Function
        • 9.4.14.3. Market Size and Forecast, By Application
        • 9.4.14.4. Market Size and Forecast, By Deployment Model
        • 9.4.14.5. Market Size and Forecast, By End User
      • 9.4.15. Indonesia Healthcare Business Intelligence Market

        • 9.4.15.1. Market Size and Forecast, By Component
        • 9.4.15.2. Market Size and Forecast, By Function
        • 9.4.15.3. Market Size and Forecast, By Application
        • 9.4.15.4. Market Size and Forecast, By Deployment Model
        • 9.4.15.5. Market Size and Forecast, By End User
      • 9.4.16. Rest of Asia Pacific Healthcare Business Intelligence Market

        • 9.4.16.1. Market Size and Forecast, By Component
        • 9.4.16.2. Market Size and Forecast, By Function
        • 9.4.16.3. Market Size and Forecast, By Application
        • 9.4.16.4. Market Size and Forecast, By Deployment Model
        • 9.4.16.5. Market Size and Forecast, By End User
    • 9.5. LAMEA

      • 9.5.1. Key Market Trends and Opportunities

      • 9.5.2. Market Size and Forecast, By Component

      • 9.5.3. Market Size and Forecast, By Function

      • 9.5.4. Market Size and Forecast, By Application

      • 9.5.5. Market Size and Forecast, By Deployment Model

      • 9.5.6. Market Size and Forecast, By End User

      • 9.5.7. Market Size and Forecast, By Country

      • 9.5.8. Brazil Healthcare Business Intelligence Market

        • 9.5.8.1. Market Size and Forecast, By Component
        • 9.5.8.2. Market Size and Forecast, By Function
        • 9.5.8.3. Market Size and Forecast, By Application
        • 9.5.8.4. Market Size and Forecast, By Deployment Model
        • 9.5.8.5. Market Size and Forecast, By End User
      • 9.5.9. South Africa Healthcare Business Intelligence Market

        • 9.5.9.1. Market Size and Forecast, By Component
        • 9.5.9.2. Market Size and Forecast, By Function
        • 9.5.9.3. Market Size and Forecast, By Application
        • 9.5.9.4. Market Size and Forecast, By Deployment Model
        • 9.5.9.5. Market Size and Forecast, By End User
      • 9.5.10. Saudi Arabia Healthcare Business Intelligence Market

        • 9.5.10.1. Market Size and Forecast, By Component
        • 9.5.10.2. Market Size and Forecast, By Function
        • 9.5.10.3. Market Size and Forecast, By Application
        • 9.5.10.4. Market Size and Forecast, By Deployment Model
        • 9.5.10.5. Market Size and Forecast, By End User
      • 9.5.11. UAE Healthcare Business Intelligence Market

        • 9.5.11.1. Market Size and Forecast, By Component
        • 9.5.11.2. Market Size and Forecast, By Function
        • 9.5.11.3. Market Size and Forecast, By Application
        • 9.5.11.4. Market Size and Forecast, By Deployment Model
        • 9.5.11.5. Market Size and Forecast, By End User
      • 9.5.12. Argentina Healthcare Business Intelligence Market

        • 9.5.12.1. Market Size and Forecast, By Component
        • 9.5.12.2. Market Size and Forecast, By Function
        • 9.5.12.3. Market Size and Forecast, By Application
        • 9.5.12.4. Market Size and Forecast, By Deployment Model
        • 9.5.12.5. Market Size and Forecast, By End User
      • 9.5.13. Rest of LAMEA Healthcare Business Intelligence Market

        • 9.5.13.1. Market Size and Forecast, By Component
        • 9.5.13.2. Market Size and Forecast, By Function
        • 9.5.13.3. Market Size and Forecast, By Application
        • 9.5.13.4. Market Size and Forecast, By Deployment Model
        • 9.5.13.5. Market Size and Forecast, By End User
  • CHAPTER 10: COMPETITIVE LANDSCAPE

    • 10.1. Introduction

    • 10.2. Top Winning Strategies

    • 10.3. Product Mapping Of Top 10 Player

    • 10.4. Competitive Dashboard

    • 10.5. Competitive Heatmap

    • 10.6. Top Player Positioning,2022

  • CHAPTER 11: COMPANY PROFILES

    • 11.1. Microsoft

      • 11.1.1. Company Overview

      • 11.1.2. Key Executives

      • 11.1.3. Company Snapshot

      • 11.1.4. Operating Business Segments

      • 11.1.5. Product Portfolio

      • 11.1.6. Business Performance

      • 11.1.7. Key Strategic Moves and Developments

    • 11.2. IBM

      • 11.2.1. Company Overview

      • 11.2.2. Key Executives

      • 11.2.3. Company Snapshot

      • 11.2.4. Operating Business Segments

      • 11.2.5. Product Portfolio

      • 11.2.6. Business Performance

      • 11.2.7. Key Strategic Moves and Developments

    • 11.3. Oracle

      • 11.3.1. Company Overview

      • 11.3.2. Key Executives

      • 11.3.3. Company Snapshot

      • 11.3.4. Operating Business Segments

      • 11.3.5. Product Portfolio

      • 11.3.6. Business Performance

      • 11.3.7. Key Strategic Moves and Developments

    • 11.4. Tableau Software

      • 11.4.1. Company Overview

      • 11.4.2. Key Executives

      • 11.4.3. Company Snapshot

      • 11.4.4. Operating Business Segments

      • 11.4.5. Product Portfolio

      • 11.4.6. Business Performance

      • 11.4.7. Key Strategic Moves and Developments

    • 11.5. Information Builders

      • 11.5.1. Company Overview

      • 11.5.2. Key Executives

      • 11.5.3. Company Snapshot

      • 11.5.4. Operating Business Segments

      • 11.5.5. Product Portfolio

      • 11.5.6. Business Performance

      • 11.5.7. Key Strategic Moves and Developments

    • 11.6. Yellowfin BI

      • 11.6.1. Company Overview

      • 11.6.2. Key Executives

      • 11.6.3. Company Snapshot

      • 11.6.4. Operating Business Segments

      • 11.6.5. Product Portfolio

      • 11.6.6. Business Performance

      • 11.6.7. Key Strategic Moves and Developments

    • 11.7. SAPSE

      • 11.7.1. Company Overview

      • 11.7.2. Key Executives

      • 11.7.3. Company Snapshot

      • 11.7.4. Operating Business Segments

      • 11.7.5. Product Portfolio

      • 11.7.6. Business Performance

      • 11.7.7. Key Strategic Moves and Developments

    • 11.8. MicroStrategy Incorporated

      • 11.8.1. Company Overview

      • 11.8.2. Key Executives

      • 11.8.3. Company Snapshot

      • 11.8.4. Operating Business Segments

      • 11.8.5. Product Portfolio

      • 11.8.6. Business Performance

      • 11.8.7. Key Strategic Moves and Developments

    • 11.9. QlikTech International AB

      • 11.9.1. Company Overview

      • 11.9.2. Key Executives

      • 11.9.3. Company Snapshot

      • 11.9.4. Operating Business Segments

      • 11.9.5. Product Portfolio

      • 11.9.6. Business Performance

      • 11.9.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR PLATFORMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR OLAP AND VISUALIZATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR QUERY AND REPORTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR PERFORMANCE MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR FINANCIAL ANALYSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR OPERATIONAL ANALYSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR CLINICAL ANALYSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR ON PREMISE MODEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR CLOUD BASED MODEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR HYBRID MODEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR HEALTHCARE MANUFACTURERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR PAYERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR OTHER END USERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA HEALTHCARE BUSINESS INTELLIGENCE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. NORTH AMERICA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 28. NORTH AMERICA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. U.S. HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 30. U.S. HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 31. U.S. HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. U.S. HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 33. U.S. HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. CANADA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 35. CANADA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 36. CANADA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. CANADA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 38. CANADA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. MEXICO HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 40. MEXICO HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 41. MEXICO HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. MEXICO HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 43. MEXICO HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. EUROPE HEALTHCARE BUSINESS INTELLIGENCE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 45. EUROPE HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 46. EUROPE HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 47. EUROPE HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. EUROPE HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 49. EUROPE HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. FRANCE HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 51. FRANCE HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 52. FRANCE HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. FRANCE HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 54. FRANCE HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. GERMANY HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 56. GERMANY HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 57. GERMANY HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. GERMANY HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 59. GERMANY HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 60. ITALY HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 61. ITALY HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 62. ITALY HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. ITALY HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 64. ITALY HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. SPAIN HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 66. SPAIN HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 67. SPAIN HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. SPAIN HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 69. SPAIN HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. UK HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 71. UK HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 72. UK HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. UK HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 74. UK HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 75. RUSSIA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 76. RUSSIA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 77. RUSSIA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 78. RUSSIA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 79. RUSSIA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. REST OF EUROPE HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 81. REST OF EUROPE HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 82. REST OF EUROPE HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. REST OF EUROPE HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 84. REST OF EUROPE HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 85. ASIA-PACIFIC HEALTHCARE BUSINESS INTELLIGENCE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 86. ASIA-PACIFIC HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 87. ASIA-PACIFIC HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 88. ASIA-PACIFIC HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. ASIA-PACIFIC HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 90. ASIA-PACIFIC HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 91. CHINA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 92. CHINA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 93. CHINA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 94. CHINA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 95. CHINA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. JAPAN HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 97. JAPAN HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 98. JAPAN HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 99. JAPAN HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 100. JAPAN HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 101. INDIA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 102. INDIA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 103. INDIA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 104. INDIA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 105. INDIA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 106. SOUTH KOREA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 107. SOUTH KOREA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 108. SOUTH KOREA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 109. SOUTH KOREA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 110. SOUTH KOREA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 111. AUSTRALIA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 112. AUSTRALIA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 113. AUSTRALIA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 114. AUSTRALIA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 115. AUSTRALIA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 116. THAILAND HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 117. THAILAND HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 118. THAILAND HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 119. THAILAND HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 120. THAILAND HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 121. MALAYSIA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 122. MALAYSIA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 123. MALAYSIA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 124. MALAYSIA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 125. MALAYSIA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 126. INDONESIA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 127. INDONESIA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 128. INDONESIA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 129. INDONESIA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 130. INDONESIA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 131. REST OF ASIA PACIFIC HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 132. REST OF ASIA PACIFIC HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 133. REST OF ASIA PACIFIC HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 134. REST OF ASIA PACIFIC HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 135. REST OF ASIA PACIFIC HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 136. LAMEA HEALTHCARE BUSINESS INTELLIGENCE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 137. LAMEA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 138. LAMEA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 139. LAMEA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 140. LAMEA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 141. LAMEA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 142. BRAZIL HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 143. BRAZIL HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 144. BRAZIL HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 145. BRAZIL HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 146. BRAZIL HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 147. SOUTH AFRICA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 148. SOUTH AFRICA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 149. SOUTH AFRICA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 150. SOUTH AFRICA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 151. SOUTH AFRICA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 152. SAUDI ARABIA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 153. SAUDI ARABIA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 154. SAUDI ARABIA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 155. SAUDI ARABIA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 156. SAUDI ARABIA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 157. UAE HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 158. UAE HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 159. UAE HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 160. UAE HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 161. UAE HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 162. ARGENTINA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 163. ARGENTINA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 164. ARGENTINA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 165. ARGENTINA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 166. ARGENTINA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 167. REST OF LAMEA HEALTHCARE BUSINESS INTELLIGENCE, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 168. REST OF LAMEA HEALTHCARE BUSINESS INTELLIGENCE, BY FUNCTION, 2022-2032 ($MILLION)
  • TABLE 169. REST OF LAMEA HEALTHCARE BUSINESS INTELLIGENCE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 170. REST OF LAMEA HEALTHCARE BUSINESS INTELLIGENCE, BY DEPLOYMENT MODEL, 2022-2032 ($MILLION)
  • TABLE 171. REST OF LAMEA HEALTHCARE BUSINESS INTELLIGENCE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 172. MICROSOFT: KEY EXECUTIVES
  • TABLE 173. MICROSOFT: COMPANY SNAPSHOT
  • TABLE 174. MICROSOFT: OPERATING SEGMENTS
  • TABLE 175. MICROSOFT: PRODUCT PORTFOLIO
  • TABLE 176. MICROSOFT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 177. IBM: KEY EXECUTIVES
  • TABLE 178. IBM: COMPANY SNAPSHOT
  • TABLE 179. IBM: OPERATING SEGMENTS
  • TABLE 180. IBM: PRODUCT PORTFOLIO
  • TABLE 181. IBM: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 182. ORACLE: KEY EXECUTIVES
  • TABLE 183. ORACLE: COMPANY SNAPSHOT
  • TABLE 184. ORACLE: OPERATING SEGMENTS
  • TABLE 185. ORACLE: PRODUCT PORTFOLIO
  • TABLE 186. ORACLE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 187. TABLEAU SOFTWARE: KEY EXECUTIVES
  • TABLE 188. TABLEAU SOFTWARE: COMPANY SNAPSHOT
  • TABLE 189. TABLEAU SOFTWARE: OPERATING SEGMENTS
  • TABLE 190. TABLEAU SOFTWARE: PRODUCT PORTFOLIO
  • TABLE 191. TABLEAU SOFTWARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 192. INFORMATION BUILDERS: KEY EXECUTIVES
  • TABLE 193. INFORMATION BUILDERS: COMPANY SNAPSHOT
  • TABLE 194. INFORMATION BUILDERS: OPERATING SEGMENTS
  • TABLE 195. INFORMATION BUILDERS: PRODUCT PORTFOLIO
  • TABLE 196. INFORMATION BUILDERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 197. YELLOWFIN BI: KEY EXECUTIVES
  • TABLE 198. YELLOWFIN BI: COMPANY SNAPSHOT
  • TABLE 199. YELLOWFIN BI: OPERATING SEGMENTS
  • TABLE 200. YELLOWFIN BI: PRODUCT PORTFOLIO
  • TABLE 201. YELLOWFIN BI: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 202. SAPSE: KEY EXECUTIVES
  • TABLE 203. SAPSE: COMPANY SNAPSHOT
  • TABLE 204. SAPSE: OPERATING SEGMENTS
  • TABLE 205. SAPSE: PRODUCT PORTFOLIO
  • TABLE 206. SAPSE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 207. MICROSTRATEGY INCORPORATED: KEY EXECUTIVES
  • TABLE 208. MICROSTRATEGY INCORPORATED: COMPANY SNAPSHOT
  • TABLE 209. MICROSTRATEGY INCORPORATED: OPERATING SEGMENTS
  • TABLE 210. MICROSTRATEGY INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 211. MICROSTRATEGY INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 212. QLIKTECH INTERNATIONAL AB: KEY EXECUTIVES
  • TABLE 213. QLIKTECH INTERNATIONAL AB: COMPANY SNAPSHOT
  • TABLE 214. QLIKTECH INTERNATIONAL AB: OPERATING SEGMENTS
  • TABLE 215. QLIKTECH INTERNATIONAL AB: PRODUCT PORTFOLIO
  • TABLE 216. QLIKTECH INTERNATIONAL AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL HEALTHCARE BUSINESS INTELLIGENCE MARKET
  • FIGURE 3. SEGMENTATION HEALTHCARE BUSINESS INTELLIGENCE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN HEALTHCARE BUSINESS INTELLIGENCE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHEALTHCARE BUSINESS INTELLIGENCE MARKET
  • FIGURE 11. HEALTHCARE BUSINESS INTELLIGENCE MARKET SEGMENTATION, BY BY COMPONENT
  • FIGURE 12. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR SOFTWARE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR SERVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR PLATFORMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. HEALTHCARE BUSINESS INTELLIGENCE MARKET SEGMENTATION, BY BY FUNCTION
  • FIGURE 16. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR OLAP AND VISUALIZATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR QUERY AND REPORTING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR PERFORMANCE MANAGEMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. HEALTHCARE BUSINESS INTELLIGENCE MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 20. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR FINANCIAL ANALYSIS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR OPERATIONAL ANALYSIS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR CLINICAL ANALYSIS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. HEALTHCARE BUSINESS INTELLIGENCE MARKET SEGMENTATION, BY BY DEPLOYMENT MODEL
  • FIGURE 24. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR ON PREMISE MODEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR CLOUD BASED MODEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR HYBRID MODEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. HEALTHCARE BUSINESS INTELLIGENCE MARKET SEGMENTATION, BY BY END USER
  • FIGURE 28. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR HEALTHCARE MANUFACTURERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR PAYERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. HEALTHCARE BUSINESS INTELLIGENCE MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 32. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 33. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 34. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 35. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 36. COMPETITIVE DASHBOARD
  • FIGURE 37. COMPETITIVE HEATMAP: HEALTHCARE BUSINESS INTELLIGENCE MARKET
  • FIGURE 38. Top player positioning, 2022
  • FIGURE 39. MICROSOFT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. MICROSOFT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. MICROSOFT: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. IBM: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. IBM: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. IBM: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. ORACLE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. ORACLE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. ORACLE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. TABLEAU SOFTWARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. TABLEAU SOFTWARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. TABLEAU SOFTWARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. INFORMATION BUILDERS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. INFORMATION BUILDERS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. INFORMATION BUILDERS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. YELLOWFIN BI: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. YELLOWFIN BI: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. YELLOWFIN BI: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. SAPSE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. SAPSE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. SAPSE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. MICROSTRATEGY INCORPORATED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. MICROSTRATEGY INCORPORATED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. MICROSTRATEGY INCORPORATED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. QLIKTECH INTERNATIONAL AB: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. QLIKTECH INTERNATIONAL AB: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. QLIKTECH INTERNATIONAL AB: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Healthcare Business Intelligence Market

Start reading.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers